Paraquat: A useful tool for the in vivo study of mechanisms of neuronal cell death

Pharmacology and Toxicology

Volumn 83, Issue 1, 1998, Pages 1-7

  Corasaniti, Maria Tiziana ^a   Strongoli, Maria Concetta ^b   Rotiroti, Domenicantonio ^a,b   Bagetta, Giacinto ^c   Nisticò, Giuseppe ^d  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF CALABRIA   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENVIRONMENTAL CHEMICAL; HERBICIDE; NEUROTOXIN; PARAQUAT;

BLOOD BRAIN BARRIER; BRAIN INJURY; CAUDATE NUCLEUS; CELL DEATH; CHOLINERGIC TRANSMISSION; HIPPOCAMPUS; IN VIVO STUDY; INTRACEREBRAL DRUG ADMINISTRATION; NEUROTOXICITY; NONHUMAN; OBSERVATION; PLAY; PRIORITY JOURNAL; PYRIFORM CORTEX; REVIEW; SUBSTANTIA NIGRA;

EID: 0031838816     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1998.tb01434.x     Document Type: Review

References (53)

1. Bagetta, G., M. T. Corasaniti, M. Iannone, G. Nisticò & J. D. Stephenson: Production of limbic motor seizures and brain damage by systemic and intracerebral injections of paraquat in rats. Pharmacology Toxicology 1992, 71, 443-448.
2. Bagetta, G., C. Del Duca, J. D. Stephenson & G. Nisticò: Neuropathological profile of 1,2,3,4-tetrahydro-9-aminoacridine (tacrine) administered systemically in rats. Pharmacol. Commun. 1993, 3, 357-367.
3. Bagetta, G., M. Iannone, I. Vecchio, V. Rispoli, D. Rotiroti & G. Nisticò: Neurodegeneration produced by intrahippocampal injection of paraquat is reduced by systemic administration of the 21-aminosteroid U74389F in rats. Free Rad. Res. 1994, 21, 85-93.
4. Barbeau, A.: Etiology of Parkinson's disease: a research strategy. Can. J. Neurol. Sci. 1984, 11, 24-28.
5. + and paraquat in rana pipiens. Life Sci. 1985, 37, 1529-1538.
6. Berisha, H. I., H. Pakbaz, A. Absood & S. I. Said: Nitric oxide as a mediator of oxidant lung injury due to paraquat. Proc. Natl. Acad. Sci. USA, 1994, 91, 7445-7449.
7. Bullivant, C. M.: Accidental poisoning by paraquat. Report of 2 cases in man. Brit. Med. J. 1966, 1, 1272-1273.
8. Burns, R. S., C. C. Chiueh, S. P. Markey, M. H. Ebert, D. Jacobowitz & I. J. Kopin: A primate model of Parkinson's disease: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 1983, 80, 4546-4550.
9. Bus, J. S. & J. E. Gibson: Paraquat: model for oxidant-initiated toxicity. Environ. Health Perspect. 1984, 55, 37-46.
10. Calò, M., M. Iannone, M. Passafaro & G. Nisticò: Selective vulnarability of hippocampal CA3 neurones after microinfusion of paraquat into the rat substantia nigra or into the ventral tegmental area. J. Comp. Pathol. 1990, 103, 73-78.
11. Caroleo, M. C., V. Rispoli, M. Arbitrio, C. Strongoli, G. Rainaldi, D. Rotiroli & G. Nisticò: Chronic administration of paraquat produces immunosuppression of T lymphocytes and astrocytosis in rats. Toxic Substance Mechanisms, 1996, 15, 183-194.
12. Choi, D. W: Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988, 1, 623-634.
13. Corasaniti, M. T. & G. Nisticò: Determination of paraquat by high-performance liquid chromatography. J. Chromatogr. 1993, 643, 419-425.
14. Corasaniti, M. T., M. C. Strongoli & G. Nisticò: Determination of paraquat in rat brain using ion-pair solid-phase extraction and reversed-phase high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. 1990, 527, 189-195.
15. Corasaniti, M. T., R. Defilippo, P. Rodinò, G. Nappi & G. Nisticò: Evidence that paraquat is able to cross the blood-brain barrier to a different extent in rats of various age. Funct. Neurol. 1991, 6, 385-391.
16. Corasaniti, M. T., G. Bagetta, P. Rodinò, S. Gratteri & G. Nisticò: Neurotoxic effects induced by intracerebral and systemic injection of paraquat in rats. Human Exp. Toxicol. 1992, 11, 535-539.
17. Corasaniti, M. T., D. Maysinger, G. Bagetta, G. Nisticò, A. Finazzi-Agrò & G. Melino: Apoptosis in nervous diseases. FORUM Trends Exp. Clin. Med. 1997, 7, 21-36.
18. De Gori, N., F. Froio, M. C. Strongoli, A. De Francesco, M. Calò & G. Nisticò: Behavioural and electrocortical changes induced by paraquat after injection in specific areas of the brain of the rat. Neuropharmacology 1988, 27, 201-207.
19. Fabisiak, J. P., V. E. Kagan, V. B. Ritov, D. E. Johnson & & J. S. Lazo: Bcl-2 inhibits selective oxidation and externalization of phosphstidylserine during paraquat-induced apoptosis. Amer. J. Physiol. 1997, 272, C675-C684.
20. Farrington, A., M. Ebert, E. J. Land & K. Fletcher: Bipyridilium quaternary salts and related compounds. V. Pulse radiolysis studies of the action of paraquat radical with oxygen. Implication for the mode of action of BH. Biochem. Biophys. Acta 1973, 314, 372-381.
21. Grant, H. C., P. L. Lantos & P. Parkinson: Cerebral damage in paraquat poisoning. Histopathology 1980, 4, 185-195.
22. Halliwell, B. & J. M. C. Gulteridge: Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 1984, 219, 1-14.
23. Hara, S., T. Endo, F. Kuriiwa & S. Kano: Different effects of paraquat on microsomal lipid peroxidation in mouse brain, lung and liver. Pharmacology Toxicology 1991, 68, 260-265.
24. Honcar, M. P., J. W. Olney & W. R. Sherman: Systemic cholinergic agents induce seizures and brain damage in lithium-treated rats. Science 1983, 220, 323-325.
25. Hughes, J. T.: Brain damage due to paraquat poisoning: a fatal case with neuropathological examination of the brain. Neurotoxicology 1988, 2, 243-248.
26. + into different areas of the rat brain. Acta Neurol. (Napoli) 1988, 10, 313-321.
27. Iannone, M., M. R. Ciriolo, G. Rotilio & G. Nisticò: Intra-nigral infusion of Cu-free superoxide dismutase prevents paraquat-induced behavioural stimulation and ECoG epileptogenic discharges in rats. Neuropharmacology 1991, 30, 893-898.
28. Kerr, J. F. R., A. H. Wyllie & A. R. Currie: Apoplosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Brit. J. Cancer 1972, 26, 239-257.
29. Koller, W. C.: Paraquat and Parkinsons disease. Neurology 1986, 36, 1147.
30. Langston, W. J., P. Ballard, J. W. Tetrud & I. Irwin: Chronic parkinsonism in humans due to a product of meperidine analog synthesis. Science 1983, 219, 979-980.
31. Lewin, R.: Parkinsons disease: an environmental cause? Science 1985, 229, 257-258.
32. 14C]diquat in frogs and mice: accumulation in neuromelanin. Neurosci. Lett. 1988, 93, 1-6.
33. McGeer, P. L., T. Kawamata, D. G. Walker, H. Akiyama, I. Tooyama & E. G. McGeer: Microglia in neurological degenerative disease. Glia 1993, 7, 84-92.
34. Melchiorri, M., R. J. Reiter, E. Sewerynek, M. Hara, L. Chen & G. Nisticò: Paraquat toxicity and oxidative damage. Reduction by melatonin. Biochem. Pharmacol. 1996 51, 1095-1099.
35. Moncada, S., R. M. J. Palmer & E. A. Higgs: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 1991, 43, 109-142.
36. Naylor, J. L., P. S. Widdowson, M. G. Simpson, M. Farnworth, M. K. Ellis & E. A. Lock: Further evidence that the blood/brain barrier impedes paraquat entry into the brain. Human Exp. Toxicol. 1995, 14, 587-594.
37. Olney, J. W., T. De Gubareff & J. Labruiere: Seizure-related brain damage induced by cholinergic agents. Nature 1983, 301, 520-522.
38. Onyon, L. J. & G. N. Volans: The epidemiology and prevention of paraquat poisoning. Human Toxicol. 1987, 6, 19-29.
39. Patel, M., B. J. Daj, J. D. Crapo, I. Fridovich & J. O. MacNamara: Requirement for superoxide in excitotoxic cell death. Neuron 1996, 16, 345-355.
40. Pellegrini-Giampietro, D. E., G. Cherici, M. Alesiani, V. Carla & F. Moroni: Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. J. Neurosci. 1990, 10, 1035-1041.
41. Plaa, G. L. & H. Witschi: Chemical drugs and lipid peroxidation. Ann. Rev. Pharmacol. Toxicol. 1976, 16, 125-141.
42. Ramachandran, S., C. N. A. Rajapakse & M. V. F. Perera: Further observations on paraquat poisoning in man. Forensic. Sci. 1974, 4, 257-266.
43. Sagar, G. R.: Uses and usefulness of paraquat. Human Toxicol. 1987, 6, 7-11.
44. Seto, Y. & T. Shinohara: Structure-activity relationship of reversible cholinesterase inhibitors including paraquat. Arch. Toxicol. 1988, 62, 37-40.
45. Sharfman, H. E. & P. A. Schwartzkroin: Responses of cells of the rat fascia dentata to prolonged stimulation of the perforant path: sensitivity of hilar cells and changes in granule cell excitability. Neuroscience 1990, 35, 491-504.
46. Smith, J. G.: Paraquat poisoning by skin absorption: a review. Human Toxicol. 1988, 7, 15-19.
47. Smith, L. L.: The identification of an accumulated system for diamines and polyamines into the lung and its relevance to paraquat toxicity. Arch. Toxicol. 1982. Suppl. 5, 1-14.
48. Smith, P. & D. Heath: Paraquat lung: a reappraisal. Thorax 1974, 29, 643-653.
49. Smith, P. & D. Heath: Paraquat. CRC Crit. Rev. Toxicol. 1976, 4, 411-445.
50. Tanner, C. M.: The role of environmental toxins in the etiology of Parkinson's disease. Trends Neurosci. 1989, 12, 49-54.
51. Webb, D. B.: Nephrotoxicity of paraquat in sheep and the associated reduction in paraquat secretion. Toxicol. Appl. Pharmacol. 1983, 68, 282-289.
52. Widdowson, P. S., M. J. Farnworth, M. G. Simpson & E. A. Lock: Influence of age on the passage of paraquat through the blood-brain barrier in rats: A distribution and pathological examination. Human Exp. Toxicol. 1996, 15, 231-236.
53. Yoshimura, Y., Y. Watanabe & T. Shibuya: Inibitory effects of calcium channel antagonists on motor dysfunction induced by intracerebroventricular administration of paraquat. Pharmacology Toxicology 1993, 72, 229-235.